Skip to content

Globus Medical GMED Number of Exercisable Options

Number of Exercisable Options at other companies

Teledyne Technologies logo
Teledyne TechnologiesTDY

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's number of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's number of exercisable options?
Globus Medical (GMED) reported number of exercisable options of 6.5M in Q1 2026.
How has Globus Medical's number of exercisable options changed year-over-year?
Globus Medical's number of exercisable options decreased by 7.6% year-over-year, from 7M to 6.5M.
What is the long-term trend for Globus Medical's number of exercisable options?
Over 4 years (2020 to 2024), Globus Medical's number of exercisable options has grown at a 9.1% compound annual growth rate (CAGR), from 4.6M to 6.5M.